Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin Addiction
Key facts
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 28 people enrolled
- Started
- 20 May 2025
- Ended
- 31 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Real-time fMRI Neurofeedback
- Sham Real-time fMRI Neurofeedback
- Record updated
- 21 October 2026
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Ability to understand, give informed consent and perform the tasks
- males and females 18-64 years of age at the time of enrollment in the study
- DSM-5 diagnosis of opioid use disorder with heroin as the primary drug of choice
- currently enrolled in a treatment facility for heroin use as the primary concern
- 2-4 week abstinence from non-prescribed opioid use/stabilized on medication assisted therapy (MAT) using either methadone and/or buprenorphine
Who cannot take part
- use of medications (current or in the last 6 months) with known CNS effects which may alter cerebral function, with the exception of psychotropics for the treatment of pain/depression/anxiety/PTSD (e.g. SSRIs) or as otherwise determined by the Principle Investigator
- present or past history of a neurodevelopmental, neurological, or a psychotic disorder
- current medical illness and/or evident infection
- head trauma with loss of consciousness for more than 30 min
- being pregnant or nursing
- contraindications to the MRI environment
Where in United States
- Icahn School of Medicine at Mount SinaiNew York, United States
About the trial
What the trial wants to find out
Support groups are an important component of addiction treatment, where individuals at more stable stages of their recovery help others by sharing personal experiences. This phenomenon suggests that the brain states of individuals further along in their recovery process may be useful in guiding those who are at an earlier stage. In this project, the researchers will test this idea and develop a personalized therapeutic tool based on real-time fMRI neurofeedback, whereby individuals with heroin use disorder (iHUD) early in treatment will learn to modulate their own brain state to more closely align with iHUD who are at later stages of treatment. Specifically, iHUD exhibit heightened reactivity to naturalistic drug cues in brain networks underlying salience attribution, reward processing, executive function and others. This fMRI brain hyperactivity pattern is reduced, concomitant with craving reductions, with about 3 months of inpatient treatment. In this neurofeedback project, iHUD who are beginning treatment will view naturalistic drug cues and receive feedback about how similar their brain activity is to the target recovery pattern, learning to modulate their own brain activity to reduce drug cue reactivity and craving. This study will offer insights into the mechanisms of recovery in addiction, particularly as coordinated across individuals with shared experience and goals. If successful, the neurofeedback-based training may lead to new brain-based and personalized tools for recovery in this devastating disorder.
The 2 groups in the trial
- Real NeurofeedbackTreatment being tested
Participants receive real-time fMRI neurofeedback reflecting their own brain activity during a drug-related movie.
Treatment: Real-time fMRI Neurofeedback
- Sham (yolked) NeurofeedbackSham treatment, for comparison
Participants receive sham real-time fMRI neurofeedback yoked to a matched participant and unrelated to their own brain activity.
Treatment: Sham Real-time fMRI Neurofeedback
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Brain-to-brain Neurofeedback During Naturalistic Dynamic Stimuli to Reduce Craving in Heroin Addiction
- Record updated
- 21 October 2026